ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

15 hedge funds and large institutions have $13.6M invested in Oramed Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
15
Holders Change
+8
Holders Change %
+114.29%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
$12.2M
2
GIM
2
Greylin Investment Management
Virginia
$798K
3
TAM
3
Telluride Asset Management
Minnesota
$299K
4
Morgan Stanley
4
Morgan Stanley
New York
$184K
5
HCM
5
Highlander Capital Management
New Jersey
$15.4K

Top Sellers

1
PM
1
Platinum Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
$12.2M 790,000 +790,000 New
GIM
2
Greylin Investment Management
Virginia
$798K 51,700 +51,700 New
TAM
3
Telluride Asset Management
Minnesota
$299K 19,371 +19,371 New
Morgan Stanley
4
Morgan Stanley
New York
$184K 11,941 +11,941 New
FNBT
5
FineMark National Bank & Trust
Florida
$54K 3,473 – –
U
6
UBS
Switzerland
$24K 1,545 +975 +171%
Wells Fargo
7
Wells Fargo
California
$21K 1,334 – –
HCM
8
Highlander Capital Management
New Jersey
$15.4K 1,000 +1,000 New
GT
9
Glenmede Trust
Pennsylvania
$15K 1,000 +1,000 New
FNYS
10
First New York Securities
New York
$11K 736 +736 New
HRIA
11
Haberer Registered Investment Advisor
Ohio
$5K 334 – –
Citigroup
12
Citigroup
New York
$5K 300 +300 New
ASN
13
Advisory Services Network
Georgia
$4K 285 +285 New
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$3K 200 – –
PM
15
Platinum Management
New York
– – -26,573 Closed
TRCT
16
Tower Research Capital (TRC)
New York
$0 20 -2,313 -99%